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PlexinA1 Autoinhibition
by the Plexin Sema Domain
essential for Sema3B, Sema3C, and Sema3F activity
(He and Tessier-Lavigne, 1997; Kitsukawa et al., 1997;
Kolodkin et al., 1997; Chen et al., 1998; Giger et al.,
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1998; Takahashi et al., 1998; Chen et al., 2000; Giger etYale University School of Medicine
al., 2000). Interestingly, Sema3B and Sema3C competeNew Haven, Connecticut 06510
with Sema3A for binding to NP1 and can function as
antagonists of NP1 receptors (Takahashi et al., 1998).
Plexins (Plex) are known to be the primary bindingSummary
sites for some semaphorins that do not bind to NP (Co-
meau et al., 1998; Winberg et al., 1998; Tamagnone et al.,Semaphorin 3A (Sema3A) binds to neuropilin-1 (NP1)
1999). Members of the plexin family have been classifiedand activates the transmembrane Plexin to transduce
into four groups: A–D (Tamagnone et al., 1999). A mem-a repulsive axon guidance signal. Here, we show that
ber of the PlexC family, VESPR (PlexC1), was isolatedSema3 signals are transduced equally effectively by
as a receptor for the viral Sema VA (Comeau et al., 1998).PlexinA1 or PlexinA2, but not by PlexinA3. Deletion
By virtue of genetic studies of Drosophila melanogaster,analysis of the PlexinA1 ectodomain demonstrates
fly PlexinA is recognized as a functional receptor forthat the sema domain prevents PlexinA1 activation in
Sema1A/B (Winberg et al., 1998). In vertebrates, PlexB1the basal state. Sema-deleted PlexinA1 is constitu-
and PlexC1 are binding sites for Sema4D and Sema7A,tively active, producing cell contraction, growth cone
respectively (Tamagnone et al., 1999). Plexin is a singlecollapse, and inhibition of neurite outgrowth. The
membrane-spanning protein that possesses a sema do-sema domain of PlexinA1 physically associates with
main near the amino terminus, followed by a cysteine-the remainder of the PlexinA1 ectodomain and can
rich motif and several glycine-proline-rich motifs (Ohtareverse constitutive activation. Both the sema por-
et al., 1995; Winberg et al., 1998.)tion and the remainder of the ectodomain of PlexinA1
Deletion studies of NP1 revealed that the amino-termi-associate with NP1 in a Sema3A-independent fashion.
nal CUB domain is crucial for semaphorin binding (GigerPlexin A1 is autoinhibited by its sema domain, and
et al., 1998; Nakamura et al., 1998). Sema3A signal trans-Sema3A/NP1 releases this inhibition.
duction also requires the extracellular, juxtamembrane
MAM domain of NP1 (Nakamura et al., 1998). Strikingly,Introduction
the transmembrane and cytoplasmic regions of NP1 are
not necessary for Sema3A action (Nakamura et al.,Accurate axonal path finding during development is criti-
1998). These findings imply that another NP-interactingcal for the establishment of nervous system structure
transmembrane protein transduces Sema3A signals toand function. Developing axons are guided by both at-
the cytoplasm. Recently, plexins were found to be NP-tractive and repulsive cues (Tessier-Lavigne and Good-
interacting, signal-transducing proteins (Takahashi etman, 1996). The semaphorin family of proteins has been
al., 1999; Tamagnone et al., 1999). NP1 and PlexA1 formcharacterized primarily as repulsive cues (Luo et al.,
a complex with an enhanced binding affinity for Sema3A,1993; Kolodkin, 1996). All semaphorins possess a con-
as compared with NP1 alone (Takahashi et al., 1999).served 500 aa sema domain (Kolodkin, 1996). Over 30
NP1 plus PlexA1, but not NP1 or PlexA1 alone, mediatessemaphorins have been identified and are classified into
contraction of the COS-7 cell perimeter in response toeight groups based on their primary sequence and
Sema3A (Takahashi et al., 1999). Overexpression of a
source (Semaphorin Nomenclature Committee, 1999).
mutant PlexA1 lacking the cytoplamsic domain blocks
Class 3 semaphorins (Sema3A–Sema3F) are secreted
Sema3A action in dorsal root ganglion (DRG) growth
semaphorins with a high-potency growth cone–collaps- cones (Takahashi et al., 1999) and Xenopus spinal axons
ing activity for certain sets of neurons (Luo et al., 1993; (Tamagnone et al., 1999). These findings strongly sup-
Koppel et al., 1997; Takahashi et al., 1998). Gene-tar- port the idea that a Plex is the signal-transducing protein
geting studies demonstrate an in vivo function for for Sema3-NP complexes. The cytoplasmic mediators
Sema3A as an axon-repulsive molecule (Behar et al., of Sema3 signaling are poorly understood, and the intra-
1996; Taniguchi et al., 1997). cellular domain of Plex has little significant sequence
Neuropilin-1 (NP1) and neuropilin-2 (NP2) have been similarity with known signaling proteins. Rac1 (Jin and
isolated as receptors for class 3 semaphorins (He and Strittmatter, 1997; Fournier et al., 2000) and collapsin
Tessier-Lavigne, 1997; Kolodkin et al., 1997). Sema3A response mediator protein (CRMP) (Goshima et al., 1995)
binds to only NP1, whereas Sema3B, Sema3C, and are downstream cytoplasmic mediators of Sema3A sig-
Sema3F bind to NP1 and NP2 (Chen et al., 1997; He and naling, but their molecular relationship to Plex is not de-
Tessier-Lavigne, 1997; Kolodkin et al., 1997; Takahashi fined. Intracellular guanosine 39,59-cyclic monophos-
et al., 1998). Antibody perturbation, virus-mediated gene phate (cGMP) levels modulate Sema3A effects on the
transfer, and gene-targeting experiments demonstrate growth cone (Song et al., 1998).
that NP1 is required for Sema3A action and that NP2 is In situ hybridization and immunohistochemistry ex-
periments demonstrate the expression of PlexA1,
PlexA2, and PlexA3 in Sema3-responsive DRG and sym-* To whom correspondence should be addressed (e-mail: stephen.
strittmatter@yale.edu). pathetic neurons (Takahashi et al., 1999; Tamagnone
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Figure 1. PlexA1 and PlexA2 but Not PlexA3
Mediate Sema3/NP-Induced COS-7 Cell Con-
traction
(A) AP-Sema3 staining of COS-7 cells ex-
pressing NP/Plex. Sema3A but not Sema3C
induces the contraction of COS-7 cells trans-
fected with NP1/PlexA1 or NP1/PlexA2. COS-7
cells expressing NP2/PlexA1 or NP2/PlexA2
are small in the presence of Sema3F. Neither
Sema3A, Sema3C, nor Sema3F induces the
contraction of COS-7 cells transfected with
NP/PlexA3. Scale bar, 70 mm.
(B) The percentage of stained cells with an
area less than 1600 mm2. Cells were trans-
fected and treated with the indicated plas-
mids and proteins. The means 6 SEM from
three to five experiments are presented.
(C) The subcellular distribution of PlexA1 and
PlexA3, as detected by anti-Myc immunohis-
tology of transfected COS-7 cells, is similar.
Scale bar, 20 mm.
(D) Sema3A-treated NP1/PlexA1-expressing
cells appear well-spread 12 hr after a 1-hr
exposure to Sema3A (reversed). Scale bar,
70 mm.
(E) Percentage of stained cells with an area
less than 1600 mm2. Cultures were trans-
fected with NP1/PlexA1 plasmids and treated
with Sema3A for 1 hr. Cells were either fixed
(NP1/PlexA1) or incubated for an additional
12 hr without Sema3A (NP1/PlexA1/rev). The
means 6 SEM from three to five experiments
are presented.
et al., 1999). However, precisely which Plex mediates logic assay allowing varied protein expression is re-
signaling by which Sema3/NP complex is not known. quired. Since this is not possible in primary neurons
Furthermore, the mechanism by which Sema3/NP com- because of endogenous Plexins and inefficient transfec-
plexes activate Plex is a mystery. Interestingly, the ecto- tion rates, we have utilized a COS-7 cell contraction
domain of Plex contains a sema domain related to assay. This assay is based on our previous observation
Sema3 ligands. What is the role of the Plex sema do- that class3 semaphorins induce the contraction of COS-7
main? In this study, we show that PlexA1 and PlexA2, cells expressing both PlexA1 and NP (Takahashi et al.,
but not PlexA3, mediate Sema3/NP signaling. Further- 1999). Here, we expressed PlexA1, PlexA2, or PlexA3
more, we present evidence that the sema domain of in COS-7 cells together with NP1 or NP2. Transfectants
PlexA1 is necessary to maintain PlexA1 in its basal inac- were incubated with 3 nM Sema3-AP (alkaline phospha-
tive state. Sema3A/NP1 complexes appear to release tase) at 378C for 1 hr and visualized by AP staining or
this autoinhibition. epitope-tag immunostaining. We measured the fraction
of cells with a reduced cellular area (Takahashi et al.,
1999). In such double-transfection assays, greater thanResults
85% of HA-NP-1/Myc-PlexA1-transfected cells express
both epitope tags (data not shown). Sema3A, but notPlexA1 and PlexA2 but Not PlexA3 Mediate
Sema3C and Sema3F, induces the contraction of NP1/Sema3/NP-Induced COS Cell Contraction
PlexA1- or NP1/PlexA2-expressing COS-7 cells (FiguresGiven that PlexA1, PlexA2, and PlexA3 are all expressed
1A and 1B). NP2/PlexA1- or NP2/PlexA2-expressingin DRG and sympathetic neurons (Takahashi et al., 1999;
COS-7 cells are contracted in the presence of Sema3F,Tamagnone et al., 1999), we considered whether PlexA2
but not Sema3A and Sema3C (Figures 1A and 1B).and PlexA3 might have physiological roles in determin-
Therefore, the function of PlexA2 appears identical withing the specificity of Sema3 signaling in combination
with NPs. For this investigation, a cell-based morpho- PlexA1 in terms of Sema3 signaling. On the other hand,
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none of these Sema3 proteins induce the contraction
of NP/PlexA3-expressing COS-7 cells (Figures 1A and
1B). This can not be attributed to poor PlexA3 expres-
sion as immunohistology and immunoblot analyses re-
veal similar PlexA1 and PlexA3 patterns (Figures 1C and
2B). Furthermore, PlexB1 and PlexB2 were also inactive
in this assay (data not shown). Thus, Sema3 signaling
requires PlexA1 or PlexA2, but specificity is largely de-
termined by the NP compliment of the cell.
A recent report described Sema3A-induced cell death
of nerve growth factor (NGF)-dependent sensory neu-
rons after a 24 hr exposure to semaphorin (Gagliardini
and Fankhauser, 1999). This raises the issue of whether
the cell contraction response is part of an irreversible
cell death response or whether it is a reversible effect
on the cytoskeleton similar to growth cone collapse.
NP1/PlexA1-expressing COS-7 cells were treated with
Sema3A for 1 hour to induce contraction and were then
incubated in Sema3A-free medium for an additional 12
hr (Figures 1D and 1E). The total number of NP1-express-
ing cells in NP1/PlexA1-transfected cultures is not re-
duced by Sema3A treatment, during the period 0–12 hr
after exposure to Sema3A (108 6 13% of control cultures
at 0 hr after treatment and 98 6 17% of control at 12
hr after treatment). Furthermore, the majority of cells
expressing NP1 resume a spread morphology during
the washout phase, indicating that the contraction re-
sponse is reversible and not secondary to the onset of
a cell death process (Figures 1D and 1E). The data are
most consistent with COS-7 contraction reflecting a cy-
toskeletal event similar to growth cone collapse.
Sema Domain Deletion Mutants of PlexA1
Are Constitutively Active
Plexins have a large extracellular portion that includes a
sema domain. The conservation of this domain between
ligand and receptor raises the questions of its functional
role. For Sema3A, it is clear that the sema domain is
the primary signal directing axonal repulsion. To explore
the role of sema domain of Plex, we have analyzed the
activity of various Plex deletion mutants. Because only
PlexA1 and PlexA2 mediate Sema3 signaling in COS-7
cells and because they are functionally identical, we
have focused on PlexA1. The PlexA1 vectors direct ex-
pression of PlexA1 lacking the sema domain (PlexA1D-
sem), the entire ectodomain (PlexA1Dect), or both ecto-
domain and transmembrane region (PlexA1cyto) (Figure
2A). Each of the PlexA1 mutant proteins includes a Myc
epitope tag. The morphology of COS-7 cells expressing
each of these proteins was assessed after a 24 hr incu-
bation by Myc immunohistology. Although wild-type
PlexA1-expressing COS-7 cells are well-spread, PlexA1D
sem- or PlexA1Dect-expressing COS-7 cells are con-
tracted (Figures 2C and 2D). We also examined PlexA3
as a control because PlexA3 does not mediate Sema3/
Figure 2. PlexA1Dsem and PlexA1Dect Are Constitutively Active in
COS-7 Cells
(A) Schematic diagram of PlexA1 deletion constructs.
(B) Immunoblotting of cell lysates of COS-7 cells expressing PlexA1, PlexA1cyto-expressing COS-7 cells are well spread, COS-7 cells
PlexA1Dsem, PlexA1Dect, PlexA1cyto, PlexA3, PlexA3Dect, or vec- expressing PlexA1Dsem or PlexA1Dect are much smaller. Scale bar,
tor. Migration of molecular size markers (kDa) is at left. 70 mm.
(C) COS-7 cells were transfected with vectors encoding Myc-tagged (D) The percentage of stained cells with an area less than 1600 mm2.
PlexA1cyto, Myc-tagged PlexA1Dsem, or Myc-tagged PlexA1Dect Cells were transfected with the indicated plasmids as in C. The
and stained with anti-Myc antibody 24 hr after transfection. Although means 6 SEM from three to five experiments are presented.
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Figure 3. PlexA1sem Associates with PlexA1Dsem
HEK293T cells were transfected with vector, or V5-tagged PlexA1-
sem together with Myc-tagged PlexA1, Myc-tagged PlexA1Dsem,
or Myc-tagged PlexA1Dect. Cell lysates were immunoprecipitated
with anti-Myc antibody and blotted with anti-V5 or anti-Myc anti-
body. PlexA1sem coprecipitates with Myc-PlexA1 or Myc-PlexA1D-
sem but not with PlexA1Dect. The molecular weights of PlexA1,
PlexA1Dsem, PlexA1Dect, and PlexA1sem are 250, 200, 70, and 75
kDa, respectively. Molecular size markers (in kDa) are shown on the
right.
NP signaling. In contrast to the case of PlexA1 mutants,
expression of a PlexA3 mutant lacking a large portion
of ectodomain (PlexA3Dect) does not alter the morphol-
ogy of COS-7 cells (Figure 2D). All of the Plex mutants are
expressed at similar levels in COS-7 cells (Figure 2B).
To examine whether the mutant PlexA1 forms were
regulated by physiologic signals, cells were cotrans-
fected with vectors directing the expression of NP and
Figure 4. PlexA1sem Reverses the Constitutive Activation of Plex-the PlexA1 mutants and were then exposed to semapho-
A1Dsemrins. The presence of NP1, Sema3A, or both does not
(A) COS-7 cells were transfected with Myc-tagged PlexA1Dsem orchange the small cellular area of PlexA1Dsem- and PlexA1D
Myc-tagged PlexA1Dect with or without V5-tagged PlexA1sem. Oneect-expressing cells (data not shown). Therefore, the
day later, cells were fixed and stained with anti-Myc antibody. Al-
PlexA1Dsem and PlexA1Dect mutant proteins appear to though COS-7 cells transfected only with PlexA1Dsem are con-
act as constitutively active receptors. tracted, COS-7 cells expressing both PlexA1Dsem and PlexA1sem
We also tested whether the transmembrane region of are much larger. The decreased spreading of PlexA1Dect-express-
ing cells is not reversed by co-expression of PlexA1sem. Scale bar,PlexA1 is required for the constitutive activity of PlexA1-
70 mm.Dect. In contrast to PlexA1Dect mutant, expression of
(B) The percentage of stained cells with an area less than 1600 mm2.PlexA1cyto mutant lacking both the ectodomain and the
Cells were transfected with the indicated plasmids. The means 6
transmembrane regions does not induce a change in SEM from three to five experiments are presented.
COS-7 cell morphology (Figures 2C and 2D). The trans-
membrane region is clearly required for the activity of the
Plex intracellular domain. Although a specific function V5-tagged PlexA1sem together with Myc-tagged wild-
might be associated with specific residues in the trans- type PlexA1, PlexA1Dsem, or PlexA1Dect into HEK293T
membrane portion, it seems more probable that this cells. Wild-type PlexA1 and mutant proteins were immu-
domain acts to tether the cytoplasmic domain at the noprecipitated with immobilized anti-Myc antibody. Im-
inner surface of the plasma membrane. munoprecipitates were immunoblotted with anti-Myc
antibody or anti-V5 antibody. Immunoblotting with anti-
Myc antibody reveals an equal expression level for wild-
PlexA1 Sema Domain Associates type PlexA1, PlexA1Dsem, and PlexA1Dect (Figure 3).
with PlexA1Dsem Protein Anti-V5 immunoblot demonstrates that PlexA1sem
Based on the fact that PlexA1Dsem is constitutively ac- physically associates both with PlexA1Dsem and wild-
tive, we hypothesized that the PlexA1 sema domain type PlexA1, but not with PlexA1Dect. Anti-V5 antibody
(PlexA1sem) maintains basal inactivity by binding and blotting of cell lysates reveals an equal amount of PlexA1
inhibiting the remainder of PlexA1. As a first step, we sem expression among these preparations. These re-
examined the association between PlexA1Dsem and sults demonstrate that the sema domain of PlexA1 binds
to the carboxyl half of the PlexA1 ectodomain.PlexA1sem. We cotransfected an expression vector for
Mechanism of Plexin Activation
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Figure 5. NP1 Associates Both with PlexA1-
sem and PlexA1Dsem
(A) HEK293T cells were transfected with vec-
tor or Myc-tagged NP1 together with vector
or V5-tagged PlexA1sem. One day later, cul-
tures were treated with or without 3–5 nM
Sema3A for 1 hr at 378C. Cell lysates were
immunoprecipitated with anti-Myc antibody
and blotted with anti-V5 antibody or anti-Myc
antibody. Note that PlexA1sem coprecipi-
tates with NP1. Molecular size markers (in
kDa) are shown in the left.
(B) HEK293T cells were transfected with vec-
tor or Myc-tagged PlexA1Dsem together with
vector or HA-tagged NP1. Twenty-four hours
after transfection, cells were treated with 3–5
nM Sema3A as in A. Cell lysates were immu-
noprecipitated with anti-Myc antibody and
blotted with anti-HA or anti-Myc antibody.
Note that NP1 coprecipitates with PlexA1D-
sem. Molecular size markers (in kDa) are
shown in the right.
(C) HEK293T cells were transfected with vec-
tor, Myc-tagged PlexA1, or Myc-tagged Plex-
A1Dsem with vector and HA-tagged NP1 or
V5-tagged PlexA1sem and HA-tagged NP1.
Twenty-four hours later, cells were incubated
with 3–5 nM Sema3A as described in this arti-
cle. Cell lysates were immunoprecipitated
with anti-Myc antibody and blotted with anti-
HA antibody, anti-Myc antibody, or anti-V5
antibody. Molecular size markers (kDa) are
shown in the left. The molecular weights of
NP1, PlexA1Dsem, PlexA1, and PlexA1sem
are 125, 200, 250, and 75 kDa, respectively.
(D) Kd (nM) of Sema3A-AP binding to COS-7
cells expressing NP1, NP1/PlexA1, NP1/Plex-
A1Dsem, or NP1/PlexA1sem. The means 6
SEM from three to five experiments are pre-
sented.
Addition of PlexA1sem Inhibits the Constitutive PlexA1sem Associates with NP1
How might PlexA1sem mediate autoinhibition of PlexA1Activity of PlexA1Dsem
If intramolecular sema domain binding to the remainder participate in Sema3A signaling through a NP1/PlexA1
complex? To begin a molecular examination, we testedof the ectodomain is required to avoid the constitutively
active state, then the PlexA1sem domain should reverse the interaction of PlexA1sem with NP1. Extracts from HEK
293T cells expressing Myc-tagged NP1 and V5-taggedconstitutive activity of PlexA1Dsem. We examined the
morphology of COS-7 cells expressing V5-tagged PlexA1 PlexA1sem were immunoprecipitated with anti-Myc anti-
body-conjugated agarose. Anti-V5 immunoblotting ofsem plus Myc-tagged PlexA1, Myc-tagged PlexA1D-
sem, or Myc-tagged PlexA1Dect. PlexA1-expressing the immunoprecipitates reveals PlexA1sem association
with NP1 (Figure 5A). This interaction is not significantlycells were detected and analyzed by anti-Myc antibody.
As described, expression of PlexA1Dsem or PlexA1Dect, affected by the presence of excess Sema3A, indicating
that the PlexA1sem binding site on NP1 is different frombut not PlexA1, induces the contraction of COS-7 cells
(Figure 2). On the other hand, COS-7 cells expressing that for Sema3A. This is consistent with our previous
finding that PlexA1 does not compete with Sema3A forboth PlexA1sem and PlexA1Dsem spread as completely
as do PlexA1 or PlexA1sem/PlexA1-expressing COS-7 binding to NP1 but actually enhances Sema3A binding
to NP1 (Takahashi et al., 1999). Indeed, cotransfectioncells (Figure 4). Because the immunoprecipitation ex-
periments show that PlexA1sem does not interact of PlexA1sem with NP1 slightly enhances the binding
of Sema3A to NP1 (Figure 5D).with PlexA1Dect, expression of PlexA1sem should not
block the constitutive activity of PlexA1Dect. Indeed, We also examined the interaction between NP1 and
PlexA1Dsem in this coimmunoprecipitation assay. HEKCOS-7 cells expressing PlexA1sem/PlexA1Dect exhibit
no increased cellular area as compared with PlexA1- 293T cells were transfected with HA-tagged NP1 and
Myc-tagged PlexA1Dsem. Anti-HA antibody blotting ofDect-expressing COS-7 cells (Figure 4). This confirms
the specificity of PlexA1sem morphologic effects for anti-Myc immunoprecipitates reveals an association be-
tween NP1 and PlexA1Dsem (Figure 5B). The additionPlexA1Dsem-expressing cells. The simplest interpreta-
tion is that PlexA1sem inhibits the constitutive activity of of Sema3A does not have a detectable effect on this
association. Furthermore, Sema3A binding affinity toPlexA1Dsem by binding to the remainder of the PlexA1
ectodomain. NP1/PlexA1Dsem-expressing COS-7 cells is more avid
Neuron
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than to NP1-expressing COS-7 cells (Figure 5D). Thus,
both the PlexA1 sema domain and the remainder of the
PlexA1 ectodomain interact with NP1 at sites distinct
from the Sema3A binding site of NP1, and the two Plex
domains cooperate to enhance Sema3A binding to NP1.
During Sema3A stimulation of a NP1/PlexA1 complex,
PlexA1sem autoinhibition of PlexA1Dsem appears to be
released. This might be correlated with a physical disso-
ciation of the PlexA1Sem domain from a Sema3A/NP-1/
PlexA1Dsem complex. Alternatively, although PlexA1-
sem may no longer repress PlexA1Dsem, it may remain
physically associated with Sema3A/NP1. To distinguish
these possibilities, we transfected Myc-tagged PlexA1
or Myc-tagged PlexA1Dsem together with HA-tagged
NP1 and V5-tagged PlexA1sem into HEK293T cells and
immunoprecipitated with anti-Myc antibody following
a 1 hr exposure to 5 nM Sema3A-AP or AP. Anti-V5
immunoblots reveal that the amount of coprecipitated
PlexA1sem from Sema3A-treated cells is almost identi-
cal to that from AP-treated cells. Therefore, PlexA1sem
remains associated with a Sema3A/NP1/PlexA1Dsem
complex, and the effect of ligand must be on the confor-
mation rather than the composition of the complex.
PlexA1sem Inhibits Sema3A-Induced Contraction
of NP1/PlexA1-Expressing COS-7 Cells
One mechanism for Sema3A activation of PlexA1 in a
NP1/PlexA1 complex is reduced autoinhibitory PlexA1-
sem binding to the remainder of the PlexA1 ectodomain.
If this mechanism is operable, then excess PlexA1sem
might be predicted to substitute for endogenous PlexA1
sem and shift an equilibrium toward PlexA1 signaling
inactivity. To explore this prediction, COS-7 cells ex-
pressing NP1/PlexA1 with or without PlexA1sem were
incubated with 3 nM of AP-Sema3A for 1 hr at 378C.
Alkaline phosphatase activity was utilized to visualize
the Sema3A binding cells. Although Sema3A induces Figure 6. PlexA1sem Inhibits Sema3A-Induced Contraction of COS-7
the contraction of NP1/PlexA1-expressing cells in the Cells Expressing NP1/PlexA1
absence of excess PlexA1sem, COS-7 cells expressing (A) COS-7 cells expressing NP1/PlexA1 with or without PlexA1sem
were treated with 3 nM Sema3A or AP. Cells treated with AP-Sema3ANP1/PlexA1/PlexA1sem do not respond to Sema3A and
were visualized via AP histochemistry. Cells treated with AP wereremain spread (Figure 6). Therefore, overexpression of
visualized by anti-HA antibody staining. Although Sema3A inducedPlexA1sem blocks Sema3A signaling in COS-7 cells.
the contraction of NP1/PlexA1-expressing cells in the absence of
The effect may be attributable to secreted PlexA1sem PlexA1sem, COS-7 cells transfected with NP1/PlexA1/PlexA1sem
throughout the culture medium or to locally higher con- are spread after Sema3A treatment. Scale bar, 70 mm.
centrations of PlexA1sem near the surface of trans- (B) The percentage of stained cells with an area less than 1600 mm2.
Cells were transfected and treated with the indicated plasmids andfected cells.
proteins. The means 6 SEM from three to five experiments are
presented.PlexA1Dsem and PlexA1Dect Are Constitutively
Active in DRG Neurons
To confirm that PlexA1Dsem and PlexA1Dect mutants growth cones. If the collapsing effect of PlexA1Dsem is
due to the activation of specific signaling cascade ratherare consitutively active in neuronal cells as well as COS-7
cells, we introduced these mutant genes into dissoci- than a nonspecific toxicity, then it should be reversed by
excess PlexA1sem, as observed in COS-7 cells (Figure 4).ated E7 chick DRG neurons by infection with recombi-
nant herpes simplex virus (HSV). One day later, growth Indeed, coinfection of PlexA1sem virus reverses PlexA1D-
sem-induced growth cone collapse, but not PlexA1Dect-cone morphology was examined. Growth cones of unin-
fected, wild-type PlexA1, or PlexA3Dect-expressing DRG induced collapse (Figure 7C). Thus, there is an intramolec-
ular plexA1 activation pathway controlling DRG growthneurons exhibited similarly broad lamelipodia. In con-
trast, the majority of PlexA1Dsem and PlexA1Dect- cone morphology.
Growth cone collapse by Sema3A is associated withexpressing DRG growth cones were collapsed and were
indistinguishable from Sema3A-treated DRG growth reduced neurite outgrowth. To the extent that the trun-
cated PlexA1 mutants function in a similar fashion tocones (Figures 7A and 7B). Thus, both PlexA1Dsem and
PlexA1Dect appear constitutively active in neuronal Sema3A-activated receptors, a reduction in neurite out-
Mechanism of Plexin Activation
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Figure 7. PlexA1Dsem and PlexA1Dect Are Constitutively Active in DRG Neurons
(A) Dissociated chick E7 DRG cultures were exposed to no virus or to PlexA1, PlexA1Dsem, PlexA1Dect, or PlexA3Dect recombinant HSV.
One to two days later, cultures were fixed and stained with rhodamine-phalloidin to visualize F-actin in the growth cones. Note that nonvirus-
infected, PlexA1 virus-infected growth cones have typical well-spread lamelipodia. In contrast, a majority of PlexA1Dsem virus or PlexA1Dect
virus-treated growth cones are collapsed. Scale bar, 20 mm.
(B) The percentage of collapsed growth cones for each condition is indicated. The means 6 SEM from three to five experiments are presented.
(C) DRG cultures were infected with HSV preparations encoding PlexA1Dsem or PlexA1Dect together with a 3-fold MOI excess of HSV
preparations encoding PlexA1 or PlexA1sem. Growth cone morphology measurements from three independent experiments are shown.
(D) Dissociated chick E7 DRG cultures were exposed to no virus or to PlexA1, PlexA1Dsem, PlexA1Dect, or PlexA3Dect recombinant HSV.
Infected neurons were cultured for 12 hr in suspension and then replated on laminin-coated dishes with or without 10 nM Sema3A for 6 hr.
Note that neurite outgrowth from PlexA1Dsem- and PlexA1Dect-expressing neurons is reduced compared with that form noninfected, PlexA1-,
and PlexA3Dect-expressing neurons. Scale bar, 20 mm.
(E) Average neurite outgrowth after viral infection. The means 6 SEM from three to five experiments are presented.
growth should result from their expression. To explore Thus, the truncated PlexA1 mutants fully activate the
Sema3A signaling pathway in DRG neurons.this prediction, dissociated E7 chick DRG neurons were
infected with recombinant HSV preparations for 12 hr
in suspension culture to allow for protein expression, PlexA1sem Blocks Sema3A-Induced Growth
and then outgrowth was assessed during a 6-hr period Cone Collapse in DRG Neurons
on laminin-coated surfaces. Neurites of noninfected, Because PlexA1sem attenuates Sema3A action in non-
PlexA1, or PlexA3Dect-expressing DRG neurons are signif- neuronal COS-7 cells, we tested whether PlexA1sem
icantly longer than PlexA1Dsem- or PlexA1Dect-express- might block Sema3A-induced growth cone collapse in
ing neurons (Figures 7D and 7E). Furthermore, 10 nM E7 chick DRG neurons. We purified PlexA1sem by virtue
of Sema3A decreases neurite outgrowth in control cul- of its His tag from the medium of PlexA1sem-expressing
tures to the same level observed in PlexA1Dsem- or HEK293T cells. Purified PlexA1sem (10 nM) was incu-
PlexA1Dect-expressing neurons. Consistent with con- bated with chick E7 DRG neurons for 30 min prior to
stitutive PlexA1 activation, 10 nM Sema3A had no further Sema3A exposure. This concentration of PlexA1sem re-
inhibitory effect on neurite outgrowth in PlexA1Dsem- duces the potency of Sema3A as a growth cone–
collapsing agent by a factor of four (Figures 8A and 8B).or PlexA1Dect-expressing neurons (Figures 7D and 7E).
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Figure 8. PlexA1sem Inhibition of Sema3A
Action in Neurons
(A) Explants of E7 chick DRG were treated
with or without 10 nM purified PlexA1sem or
PlexA1sem virus. Rhodamine-phalloidin stain-
ing of DRG growth cones is presented. Either
purified PlexA1sem or PlexA1sem virus in-
fection reduces 100 pM Sema3A-induced
growth cone collapse. Scale bar, 20 mm.
(B and C) Sema3A dose–response curve for
DRG growth cone collapse. (B) DRG cultures
were treated with purified PlexA1sem or
buffer for 30 min in DRG medium, and then
growth cone collapse assays were performed
with the indicated concentrations of Sema3A.
(C) Growth cones were treated with or without
PlexA1 virus or PlexA1sem virus for 24–48
hr, and growth cone collapse was performed
with various concentrations of Sema3A. The
means 6 SEM from three to five experiments
are presented.
As an alternative method to provide more complete not attenuate neurite outgrowth from PlexA1Dsem- or
PlexA1Dect-expressing DRG neurons.receptor silencing, PlexA1sem was coexpressed with
endogenous Sema3A receptor complexes via HSV in- What is the role of the PlexA1 sema domain in the
NP/PlexA1 complex? We demonstrate that PlexA1semfection of E7 chick DRG neurons. Overexpression of full-
length PlexA1 does not change the responsiveness of associates with both NP1 and the remainder of PlexA1.
Because coprecipitation is not modified by the presenceDRG growth cones to Sema3A. On the other hand, ex-
pression of PlexA1sem shifts the dose response curve of Sema3A, the PlexA1 sema domain must bind to NP1
at a site different from the Sema3A binding site of NP1.for Sema3A to the right by a factor of 10 (Figures 8A
and 8C). These results demonstrate that the sema do- Indeed, coexpression of PlexA1sem with NP1 enhances
Sema3A avidity for NP1. PlexA1Dsem also associatesmain of PlexA1 can significantly reduce Sema3A-induced
growth cone collapse in DRG neurons. with NP1 in a Sema3A-independent fashion and co-
expression of PlexA1Dsem increases Sema3A affinity
for NP1. This implies that NP1 interacts with three part-Discussion
ners at three distinct sites. PlexA1sem and the remain-
der of PlexA1 ectodomain cooperate to increase theMechanism of Plexin Activation
The major finding of the present study is that a mutant Sema3A affinity for NP1. In the NP1/PlexA1 complex,
PlexA1 sema domain interactions with both NP1 and thePlexA1 lacking the sema domain exhibits constitutive
activation. This mutant reduces COS-7 cell area, col- remainder of the PlexA1ectodomain may keep PlexA1
silent. Presumably, Sema3A binding to NP1 results in alapses DRG growth cones, and inhibits neurite out-
growth from DRG neurons. These data imply that the dramatic conformational change in this complex. The
simplest model is that this conformational change physi-sema domain of PlexA1 restricts PlexA1 to a basal inac-
tive state by binding to the remainder of the ectodomain. cally separates and functionally reduces PlexA1sem ef-
fects on the remainder of the PlexA1 ectodomain (FigureIn support of this interpretation, we show that PlexA1-
sem physically associates with PlexA1Dsem and that 9). In support of such a conformational dissociation of
the two PlexA1 domains, excess PlexA1sem can reversePlexA1sem coexpression attenuates the constitutive ac-
tivity of PlexA1Dsem. The constitutive activity of PlexA1D constitutive activation or Sema3A-induced PlexA1 acti-
vation. Although the two PlexA1 domains are function-sem and PlexA1Dect does not appear to be due to
a nonphysiologic conformational change induced by ally dissociated by Sema3A binding to NP-1, they remain
bound in a NP1-dependent complex of altered confor-large-scale deletion because (1) PlexA1sem reverses
the constitutive activity of PlexA1Dsem, (2) PlexA3Dect mation. The NP1 antagonists, Sema3C, Sema3B, and
Sema3F, are expected to occupy the Sema3A site butis inactive, and (3) exposure to excess Sema3A does
Mechanism of Plexin Activation
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Figure 9. A Model for Plexin Activation
For full-length PlexA1, PlexA1sem binds to
the remainder of PlexA1 ectodomain and
maintains activity at a low basal level. PlexA1D
sem and PlexA1Dect are constitutively active
because of the lack of inhibition by PlexA1-
sem. The constitutive activity of PlexA1Dsem
is reversed by PlexA1sem binding to the re-
mainder of PlexA1 ectodomain. In the NP1/
PlexA1 complex, PlexA1sem binds both to
NP1 and the remainder of PlexA1 ectodomain
and inhibits the activation of PlexA1. Sema3A
binding to NP1 induces a conformational
change in the complex and dissociates Plex-
A1sem from the remainder of PlexA1 ectodo-
main. This leads to the activation of PlexA1
signaling. Excess PlexA1sem can bind to the
“empty” PlexA1 ectodomain and inhibit the
PlexA1 signaling.
not result in this conformational shift and the release of Specificity of Semaphorin Signaling
Clearly, the signaling specificity within the large sema-PlexA1sem from the remainder of the PlexA1 ecto-
phorin family is crucial to an understanding of their roledomain.
in biology. Previously, we found that PlexA1 associatesAfter conformational changes occur in the extra-
with NP and mediates Sema3A signaling (Takahashi etcellular domains of PlexA1, they may be transmitted
al., 1999). Here, we demonstrate that PlexA1 and PlexA2intramolecularly across the lipid bilayer. Alternatively,
are equally active in transducing Sema3 signals. On themacromolecular aggregation state may play a role in
other hand, PlexA3 is inactive in these assays as a medi-transducing conformational changes to the cell interior,
ator of Sema3/NP signaling. The biological function ofas for tyrosine kinase receptors (Yarden and Schlessinger,
PlexA3 in DRG and sympathetic neurons is not clear.1987). Previously, we have shown that Sema3A induces
Because PlexA3 can form a complex with NPs (Tamag-the aggregation of Plex on DRG growth cones and spec-
none et al., 1999), it might function as an inactive, buff-ulated that the formation of Plex aggregates might be
ering component. Further work is required to determinecrucial for the activation of signaling (Takahashi et al.,
whether multiple PlexAs are associated in a single com-1999). It is conceivable that PlexA1 sema domain bind-
plex with Sema3 dimers and NP multimers.ing to the remainder of PlexA1 ectodomain prevents the
At least in part, the inactivity of PlexA3 is determinedformation of higher order aggregates. Because PlexA1-
by the intracellular domain, as the PlexA3Dect protein
Dect is constitutively active, this model would imply that
is not constitutively active in either nonneuronal or neu-the transmembrane 1 cytoplasmic domain is inherently
ronal cells. Given that the PlexA1, PlexA2, and PlexA3capable of aggregate formation. It remains unclear
intracellular domains are quite similar, the current find-
whether aggregate formation is the sine qua non of acti-
ings may simplify a search for those residues that de-
vation or whether it is a secondary consequence of sig- termine signaling competency. Although PlexB1 and
nal transduction. It remains undetermined whether in- PlexB2 are inactive as mediators of NP/Sema3 signals,
duction of full-length PlexA1 aggregation is sufficient to we have not examined whether the PlexB1Dect and
activate signaling. PlexB2Dect proteins might be constitutively active. Be-
A number of semaphorins outside of class 3 can bind cause the PlexB family possesses furin protease recog-
directly to Plexins (Comeau et al., 1998; Winberg et al., nition sites in the juxtamembrane region of ectodomain
1998; Tamagnone et al., 1999). Presumably, these sema- (Tamagnone et al., 1999), proteolysis might regulate the
phorins disrupt the cis binding of the Plex sema domain activity of PlexB1 and PlexB2.
and activate signaling. They might do so binding to the With regard to Sema3C, no combination of one Plex
Plex sema domain as a sema dimer by competing with and one NP was sufficient for a cell morphology re-
the Plex sema domain for interaction with the remainder sponse in COS-7 cells. Although it remains possible that
of the Plexin protein or by a combination of these mecha- the appropriate plexin has not yet been tested, it seems
more likely that both NP1 and NP2 are required fornisms.
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(9E10). In other experiments, Myc-NP1 and V5-PlexA1sem, Myc-Sema3C activity. This is supported by the finding that
PlexA1Dsem and HA-NP1, Myc-PlexA1 and HA-NP1 together witheither anti-NP1 antibody or anti-NP2 antibody can block
V5-PlexA1sem, or Myc-PlexA1Dsem and HA-NP1 together with V5-the Sema3C activity in sympathetic neurons (Chen et
PlexA1sem were expressed. After a 1-hr incubation with or without
al., 1998). Sema3A (5 nM), cells were lysed as described (Takahashi et al.,
1999). Cell extracts were immunoprecipitated with anti-Myc anti-
body-conjugated agarose beads as described (Takahashi et al.,Signaling Molecules Downstream of Plexin
1999). Immunoprecipitates were analyzed with anti-V5 antibody,CRMP (Goshima et al., 1995), rac1 (Jin and Strittmatter,
anti-HA antibody, or anti-Myc antibody as described (Takahashi et
1997; Fournier et al., 2000), cGMP (Song et al., 1998), al., 1999).
and tyrosine kinase activity (Tamagnone et al., 1999)
have all been associated with Sema3A signaling and/ COS-7 Cell Morphology and Binding Assay
or the Plex cytoplasmic domain. However, the exact COS-7 cells (1 3 105) were transfected with 1 mg of PlexA1-
pcDNA3.1-MycHis, PlexA1Dsem-pSecTag2, PlexA1Dect-pSecTag2,pathway from cytoplasmic Plex to axon repulsion re-
PlexA1cyto-pSecTag2 together with 1 mg of pcDNA3.1-MycHis ormains poorly defined. Because dominant negative rac1
PlexA1sem-pcDNA3.1-V5His. After 24 hr, these cells were fixed withblocks Sema3A-induced contraction of NP1/PlexA1-
3.7% formaldehyde in phosphate-buffered saline. Cells were incu-
expressing COS-7 cells (T. Takahashi and S. M. Stritt- bated with anti-Myc antibody (9E10) and fixed with 3.7% formalde-
matter, unpublished data), as well as Sema3A-induced hyde again. After 2 hr at 658C to inactivate endogenous alkaline
growth cone collapse in DRG neurons (Jin and Strittmat- phosphatase, cells were incubated with alkaline-phosphatase-con-
jugated anti-mouse IgG. Cells were visualized by the deposition ofter, 1997), similar signaling pathways are likely to oper-
insoluble AP reaction product from nitro blue tetrazolium (NBT) andate in both cell types. The current identification of consti-
5-bromo-4-chloro-3-indolyl-phosphate (BCIP). The size of stainedtutively active Plexins should greatly facilitate further
cells was analyzed as described (Takahashi et al., 1999). In the other
analysis of downstream signaling events. Of note, the experiments, COS-7 cells were transfected with PlexA1-pcDNA-
cytoplasmic domain of PlexA1 requires its membrane- MycHis (1 mg) and HA-NP1-pcDNA1 (0.25 mg) together with PlexA1-
tethering transmembrane domain for constitutive activ- sem-pcDNA3.1-V5His (1 mg). After 24 hr, cells were incubated with or
without 3 nM of AP-Sema3A at 378C for 1 hr as described previouslyity. In this light, it is interesting to note that significant
(Takahashi et al., 1999). Cells were then washed and fixed. Afterproportions of CRMP and rac1 are membrane-associ-
heat inactivation, Sema3A binding was visualized by NBT/BCIP.ated (Goshima et al., 1995; Michaely et al., 1999). Fur-
Cells not treated with Sema3A were incubated with AP for 1 hr
thermore, the activity of several GTPase-regulating pro- at 378C. The morphology of such cells was monitored by anti-HA
teins is regulated by membrane association (Hasegawa immunohistology.
et al., 1996). For Sema3A binding assays, COS-7 cells were transfected with
NP1, NP1/PlexA1, NP1/PlexA1Dsem, or NP1/PlexA1sem. Twenty-
four hours after transfection, cells were incubated with various con-Experimental Procedures
centrations of Sema3A-AP for 2 hr as described (Takahashi et al.,
1999). After washing, cells were fixed and heat inactivated as de-PlexA1, PlexA2, and PlexA3 Expression Vectors
scribed previously in this article. Binding of Sema3A-AP to COS-7The plasmids containing PlexA1-pcDNA3.1-Myc-His, PlexA1-
cells was quantitated as described (Takahashi et al., 1998; Taka-pHSVPrPUC, HA-tagged NP1-pcDNA1, and Myc-tagged NP1-
hashi et al., 1999).pcDNA1 were described previously (Nakamura et al., 1998; Taka-
hashi et al., 1998; Takahashi et al., 1999). To obtain PlexA1Dsem-
Recombinant HSV PreparationspSecTAG2, a cDNA fragment of PlexA1 (aa 542–1874) was amplified
The coding regions of PlexA1Dsem, PlexA1Dect, and PlexA3Dectby polymerase chain reaction (PCR) and ligated into the BamHI
(including the pSecTag2 derived signal peptide) were PCR amplifiedand EcoRV sites of pSecTag2A. To express PlexA1Dect, a PCR-
and ligated to pHSVPrPUC vector. For PlexA1sem virus, the codingamplified fragment of PlexA1 (aa 1218–1874) was ligated into the
region of PlexA1sem was excised from pcDNA3.1-MycHis vectorBamHI and EcoRV sites of pSecTag2A. To obtain PlexA1sem-
and ligated to pHSVPrPUC vector. The resulting plasmids (2mg) werepcDNA3.1-V5-His, the mouse PlexA1 cDNA (Kameyama et al., 1996)
transfected into 2–2 cells (3 3 105) with lipofectamine or FUGENEwas digested with EcoRI and HpaI and then ligated into the EcoRI
and then superinfected with 5dl1.2 HSV helper virus 1 day later asand EcoRV sites of pcDNA3.1-V5-HisC. A fragment of PlexA1 encod-
described (Nakamura et al., 1998; Takahashi et al., 1998; Takahashiing the intracellular domain (aa 1266–1874) was PCR amplified and
et al., 1999). Recombinant virus was amplified through three pas-ligated into pcDNA3.1-Myc-HisC. Human PlexA2 cDNA (Kazusa,
sages and stored at 2808C.DNA Research Institute; cDNA clone KIAA0463) was digested with
KpnI and NotI, and the DNA fragment (aa 1–1885) was ligated into
pcDNA3.1-Myc-HisA. For expression of PlexA3Dect, a DNA frag- Purification of PlexA1sem Protein
ment (aa 1072–1872) was amplified by PCR from E15 mouse cDNA HEK293T cells were transfected with PlexA1sem-pcDNA3.1-MycHis
(Quick-Clone; Clontech, Palo Alto, CA) and then digested with by the FuGENE-6 method. Three days after, 200 ml of medium were
BamHI and XhoI. This fragment was ligated into pSecTag2A. To collected and supplemented with Imidazole to 25 mM and with NaCl
obtain full-length PlexA3, a DNA fragment (aa 21–1071) was ampli- to 200 mM. The medium was passed through a 0.45 mm filter and
fied by PCR from the E15 mouse cDNA described previously in this applied to a 0.75 ml Ni-containing resin. Protein was eluted with
article and digested with HindIII and BamHI. This fragment was then 200 mM Imidazole, 50 mM NaCl, pH 7.3.
ligated into PlexA3Dect-pSecTag2A.
DRG Growth Cone and Neurite Outgrowth Analysis
The culture and HSV infection of chick E7 DRG explants has beenCoimmunoprecipitation
HEK293T cells (1 3 106) were transfected with the expression vector described previously (Nakamura et al., 1998; Takahashi et al., 1998;
Takahashi et al., 1999). Growth cone collapse assays were per-for Myc-PlexA1 (1mg), Myc-PlexA1Dsem, or Myc-PlexA1Dect to-
gether with V5-PlexA1sem by the FuGENE-6 method. After 24 hr, formed as described (Igarashi et al., 1993; Goshima et al., 1995;
Takahashi et al., 1997). For experiments with purified PlexA1sem,cells were lysed with ice-cold immunoprecipitation buffer as de-
scribed previously (Takahashi et al., 1998; Takahashi et al., 1999). we preincubated cultures with 10 nM of PlexA1sem for 30 min and
then performed standard growth cone collapse assays. In tests ofProtein from cell extracts was immunoprecipitated with anti-Myc
(9E10) antibody-conjugated agarose beads as described (Takahashi the constitutive activity of PlexA1 mutants, E7 DRG neurons were
infected with HSV preparations for PlexA1, PlexA1Dsem, PlexA1-et al., 1998; Takahashi et al., 1999). Bound protein was analyzed by
immunoblot with either anti-V5 antibody or anti-Myc antibody Dect, or PlexA3Dect . After 24–48 hr, DRG neurons were fixed with
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ice-cold 3.7% formaldehyde/20% sucrose in phosphate-buffered Jin, Z., and Strittmatter, S.M. (1997). Rac1 mediates collapsin-1-
induced growth cone collapse. J. Neurosci. 17, 6256–6263.saline. Growth cones were visualized by rhodamine-phalloidin stain-
ing. For the analysis of neurite outgrowth, dissociated E7 chick DRG Kameyama, T., Murakami, Y., Suto, F., Kawakami, A., Takagi, S.,
neurons were preplated on uncoated plastic dishes in the presence Hirata, T., and Fujisawa, H. (1996). Identification of plexin family
of HSV preparations encoding PlexA1, PlexA1Dsem, PlexA1Dect, or molecule in mice. Biochem. Biophys. Res. Commun. 226, 396–402.
PlexA3Dect. After 12 hr, neurons were collected and replated on Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M.,
laminin-coated dishes with or without 10 nM Sema3A. Six hours Bekku, Y., Yagi, T., and Fujisawa, H. (1997). Neuropilin-semaphorin
later, cells were fixed stained, and neurite outgrowth was quanti- III/D-mediated chemorepulsive signals play a crucial role in periph-
tated (Goshima et al., 1995; Jin and Strittmatter, 1997). Neuronal eral nerve projection in mice. Neuron 19, 995–1005.
survival was indistinguishable between cultures expressing PlexA1,
Kolodkin, A.L. (1996). Semaphorins: mediators of repulsive growthPlexA1Dsem, PlexA1Dect, and PlexA3Dect.
cone guidance. Trends Cell Biol. 6, 15–22.
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